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Osteopetrosis or marble bone disease is a rare heritable skeletal disorder  that the bones becoming 
denser, caused by aberrant osteoclast-mediated bone resorption. This condition reveals a spectrum 
of heterogeneity of genetic defects. This metabolic disorder has an unequal balance between new 
bone formation and old bone resorption. Thus the result is increased bone density on radiographs. 
Presented here is a 25 years-old Persian female presented to our clinic with the chief complaint of 
low back pain and limping. She explained that her problem had been present for a long time. There 
were no other significant findings in past medical history and her parents and three siblings did not 
have any disorder of note, however, the parents were first cousin. No specific laboratory 
abnormalities found in the initial evaluation. On physical examination, an antalgic gait is noted. A 
Bone biopsy from proximal medial tibia revealed increased density of the cortex and part of 
medullary canal with hematopoietic marrow and irregular and thickened bone trabeculae. These 
factors suggested osteopetrosis disease. Osteopetrosis should be kept in mind as a rare cause of low 
back pain and limping and should be mentioned as a differential diagnosis of fluorosis, Paget’s 
disease, malignancies (lymphoma, osteoblastic cancer metastases) and myelosclerosis.  
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Osteopetrosis is a rare congenital disorder of 
osteoclast function and /or development 
characterized by impaired bone resorption 
and increased density of all bones1-3. The long 
bonesare usually shortened and frequently 
exhibit a remodeling defect (the Erlenmeyer 
flask deformity) characterized by loss of the 
normal metaphyseal flare. 
Despite the increased bone density, the 
disease is often complicated by multiple 
fractures resulting from a disturbed Micro- 
architecture. Reduction in the size of the 
foramina in the skull leads to optic and 
auditory nerve compression with visual and 
auditory defect. Several rare genetic 
mutations are present. These mutations lead 
to varying degrees of dysfunction of the 
osteoclasts4,5. This causes an imbalance 
between   the   osteoclasts     and   osteoblasts, 
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resulting in excess bone formation and 
abnormal bone modeling. The end result is 
variable depending on the severity of 
osteoclast dysfunction and can range from 
asymptomatic adults with normal life 
expectancy to early infantile death6. Two 
genetic types of osteopetrosis are known: 
autosmal dominant and autosomal recessive4. 
Autosomal dominant osteopetrosis (1/20000 
birth) also known as osteopetrosis tarda or 
Albers Schoinberg disease presents in 
adulthood. Most patients have a normal 
lifespan and are asymptomatic approximately 
50% of the time6. The most common clinical 
manifestation is increased fragility of bone 
leading fractures. Autosomal recessive 
osteopetrosis also known as osteopetrosis 
congenita, is a rare disease of infancy to early 
childhood with a rate of 1/300000 birth 
worldwide with an exception of Costa Rica 
where the rate is much higher (3-4/100.000 
birth). It can cause bone marrow failure due 
to obliteration of the marrow cavity, as well 
as blindness and deafness due to narrowing of 
the bony neural formation6.  
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Most children with autosomal recessive 
osteopetrosis do not survive beyond 10 years 
of age. Intermediate recessive osteopetrosis 
and marble bone or marble brain disease are 2 
types of autosomal recessive osteopetrosis 
with different clinical presentations. This type 
caused by a mutation in the gene encoding 
CAII resulting in carbonic anhydrase II 
deficiency. The patients with intermediate 
recessive osteopetrosis are affected to degree 
between severe autosomal recessive 
osteopetrosis and mild autosomal dominant 
osteopetrosis and may have a short stature, 
anemia, hepatomegaly, and multiple fractures. 
In marble bone or marble brain disease, 
patients develop renal tubular acidosis and 
intracranial calcifications and may be 
developmentally disabled. The few X-Linked 
cases have been associated with ectodermal 
dysplasia, lymphedema and immune 
deficiency1-3,5,6. 
Case Report: 
A 25 year old Persian female presented to our 
clinic with the chief complaint of low back 
pain and limping. She explained that her 
problem had been present for a long time. 
There were no other significant findings in 
past medical history and her parents and three 
siblings did not have any disorder of note, 
however, the parents were first cousin. 
On physical examination, an antalgic gait is 
noted. A shortening of 2 cm and fixed 
adduction contracture and limitation of all hip 
motions at the left side were additional 
findings. 
X-rays and biochemical laboratory 
investigations were ordered. No specific 
laboratory abnormalities found in the initial 
evaluation. Serum calcium, phosphate and 
alkaline phosphatase and sedimentation rate 
were particularly in normal range. On 
lumbosacral x-ray, diffuse sclerosis of 
vertebrae and sandwich bone appearance 
were seen. 
The same feature of diffuse sclerosis was 
apparent on pelvic and knee x-rays. (Figures 
(1, 2)). 
A Bone biopsy from proximal medial tibia 
was done. 
On microscopic examination, whole-mount 
transverse sections of the specimen showed 
increased density of the cortex and part of 
medullary canal with hematopoietic marrow. 
Other sections revealed irregular and 
thickened bone trabeculae (Figure 3) as well 
as central core of calcified cartilage. 
Figure (1): Pelvic x-ray in this patient shows 
thick dense bone. 
Figure (2): knee x-ray of the patient with 
marble bone disease. 
Numerous osteoclast–like cells adjacent to the 
bony trabeculae are present (Figure 4). Based 
on radiographic, clinical and histological 
presentation; the final diagnosis was 
osteopetrosis most probably autosomal 
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dominant form. We suggest total hip 
arthroplasty for her and she want to decide it. 
Figure (3): Microscopic section reveals 
extremely thick bone trabeculae. 
Figure (4): microscopic section shows 
irregular bone trabeculae with central core of 
cartilage. 
DISCUSSION: 
Radiography and computed tomography are 
the most useful modalities to evaluate 
osteopetrosis. Magnetic resonance imaging 
can be helpful in more severe cases of 
autosomal recessive osteopetrosis to 
determine the amount of remaining marrow 
space. Bone marrow distribution of the 
disease is best shown by technetium-99m 
sulfur colloid scintigraphy8. On radiographs, 
osteopetrosis presents as dense bone or 
osteosclerosis9. A characteristic radiographic 
appearance of osteopetrosis has been termed 
bone-in-bone, in which the dense internal 
sclerosis appears as cortical bone inside the 
medullary cavity of the bone8,9.  
This is most commonly seen in the iliac wing 
and epiphyses of the femur, humerus, tarsal 
bones and ribs8. In the vertebrae, dense 
sclerosis of the superior and inferior endplates 
can be observed and has been termed 
sandwich vertebra4. Autosomal recessive 
osteopetrosis presents early in infants. 
Pathological fractures are typical. The 
abnormality in bone remodeling can result in 
under-tubulation of the long bones, which can 
have a club like shape or an Erlenmeyer flask 
appearance. Ribs tend to be sclerotic, and 
horizontal lucent lines may be present4,8. 
Individuals with autosomal dominant 
osteopetrosis tend to have symmetrical 
abnormalities. Two types, based on 
radiograph appearance, are preserved. Type 1 
is characterized by marked cranial sclerosis 
and calvarial thickening with minimal or no 
sclerosis in the vertebrae, patchy sclerosis in 
the pelvis, and diffuse sclerosis and cortical 
thickening in the tubular bones. Type 2 is 
characterized by a normal calvarium except 
for sclerosis at the skull base, vertebral 
involvement with thickening and sclerosis of 
the endplates, and dense sclerotic bones in the 
pelvic, especially along the iliac arcs. 
Transverse sclerotic banding is also common. 
Dental caries and abscesses, as well as 
sensory or motor loss in cranial nerves 
associated with forminal stenosis, are also 
indicators of type 2 autosomal recessive 
osteopetrosis7,8. 
Grossly the density of the affected bone is 
increased and they may weigh two to three 
times more than normal despite usually being 
somewhat smaller than normal. On sectioning 
the bone tissue is very compact, showing loss 
of the normal architecture10. 
Microscopically extremely dense and 
irregular bone trabeculae are usually seen, 
nearly all of which have a central core of 
cartilage. Although a paucity of osteoclasts 
has been reported in osteopetrosis, 
microscopic examination shows that 
osteoclasts are often abundant10. 
When examined under electron microscope, 
these osteoclasts lack ruffled borders, and 
although they are close to the bone, they do 
not show the normal cytologic features of 
actively resorbing osteoclasts10.                
Most cases of osteopetrosis are associated 
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with a failure of osteoclast function resulting 
in disturbances of intracellular and 
extracellular PH of the osteoclast resorption 
compartment which leads to impaired 
resorption of organic acid and inorganic bone 
matrix. In some cases there is a failure of 
osteoclast development, this autosomal 
recessive form is associated with a mutation 
of the RANKL gene1-3,5. 
The increased bone sclerosis may show 
reduced marrow space and impaired myeloid 
hematopoiesis, anemia, bone marrow failure, 
and accompanied by extramedully 
hematopoiesis with hepatosplenomegally and 
leukoerythroblastic blood picture7. 
The differential diagnosis includes primary 
sclerosing conditions of bone caused by 
osteoclast dysfunction and need to be 
distinguished from the large number of 
conditions in which bone sclerosis can occur 
as a secondary phenomen. Some alternative 
diagnoses to consider include fluorosis; 
Paget’s disease (sclerosing from), 
malignancies (lymphoma, osteoblastic cancer 
metastases) and myelosclerosis10. 
Treatment for osteopetrosis is largely based 
on symptoms4. Autosomal dominant 
osteopetrosis requires no treatment unless 
pathologic fractures exit. However, more than 
half of all patients diagnosed with autosomal 
dominant osteopetrosis will need orthopedic 
surgery at some time Because of the abnormal 
bone remodeling, delayed union or nonunion 
of fractures are common problems11. 
During surgical fixation of fractures in these 
patients, problems can be encountered due to 
the hard and brittle bones, including 
perioperative fracture at the site of stress 
risers, such as screw holes and broken drill 
bits8,11. Due to the increased complications of 
surgery, casting of fractures is the preferred 
treatment when possible11. Patients with 
autosomal recessive osteopetrosis may need 
red blood cell and platelet transfusions, and 
haematopoietic stem cell transplantation 
(HSCT) in severe cases of bone marrow 
dysfunction4,5 which is successful in 
approximately 50% of cases. Interferon -γ, 
can improve immunity, increase bone 
resorption, and enlarge the marrow space4,11. 
Other therapies that can be useful in 
stimulating osteoclast function in autosomal 
recessive osteopetrosis in clued calcium 
restriction and treatment with calcitriol, 
steroids, and parathyroid hormone12,13. 
After HSCT there is gradual resorption of the 
abnormal bone structure, regression of the 
cartilaginous plate, and expansion of the 
medullary space with abundant 
hepmatopoietic tissue. Also regression of 
splenomegaly and reversal of 
leukoerythroblastic blood picture are 
present14,15. 
CONCLUSIONS: 
Osteopetrosis should be kept in mind as a rare 
cause of low back pain and limping and 
should be mentioned as a differential 
diagnosis of fluorosis, Paget’s disease, 
malignancies (lymphoma, osteoblastic cancer 
metastases) and myelosclerosis. On the other 
hand diagnosis of this disease and rule out the 
others can differentiate the prognosis of the 
patients. 
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